A Ring-type Wearable Device for Atrial Fibrillation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-23

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates diagnostic performance of a ring-type wearable device for detecting atrial fibrillation. This is a prospective cohort registry study began after the date of IRB approval and until 31th Dec. 2019. The eligible criteria are (1) those who admitted the institution for elective direct-current cardioversion of persistent atrial fibrillation, and (2) aged 19 years or more. The exclusion criteria are (1) those aged less than 19 years, (2) those who are not eligible to perform cardioversion by any reasons. This study aims to recruit 200 participants in total. The participants are required to record photoplethysmographic signals by the ring device in addition to routine procedures of direct-current cardioversion, hence, the study is at minimal risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Ring-type Wearable Device for Atrial Fibrillation Among Ambulatory Patients

NCT04024124

Atrial Fibrillation

UNKNOWN

DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)

NCT05795842

Stroke, Ischemic

RECRUITING

REal-worLd vAlidaTION of PhotoPlehtysmoGraphy (for Atrial Fibrillation Detection)

NCT06028893

Atrial Fibrillation

COMPLETED NA

Testing the Performance of Smartphones and Their Accessories in Detecting Irregularly Irregular Heart Rhythm

NCT07154303

Atrial Fibrillation (AF)

ENROLLING_BY_INVITATION

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

NCT06847932

Premature Atrial Complexes Atrial Arrhythmias Artificial Intelligence (AI) +2 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Study title: Diagnostic Performance of a Ring-type Wearable Device Using Deep Learning Analysis of Photoplethysmographic Signals for Detecting Atrial Fibrillation.
2. Study type: Investigator initiated study.
3. Study design: Prospective observational cohort registry design.
4. Sponsor: Sky Labs, Inc., Republic of Korea.
5. The aim of the study: To evaluate diagnostic performance of a ring-type wearable device for detecting atrial fibrillation.
6. Study period: From the date of IRB approval to 31th Dec. 2019.
7. The size of study population: 200 participants
8. The eligibility criteria:

(1) Those with persistent atrial fibrillation (2) Those who admitted the institution for elective direct-current cardioversion (3) Those aged 19 years or more 9. The exclusion criteria:

(1) Those with other forms of cardiac arrhythmias (2) Those aged less than 19 hears (3) Those who are not eligible to perform electrical cardioversion 10. Procedures of the study

1. A participant is under the routine procedures of direct-current cardioversion.
2. On admission, a participant is given with detailed information of the study.
3. After the informed consent, the only additional procedure due to the study is recording photoplethysmographic signal by wearing a ring-type device.
4. Recorded signals are evaluated without encompassing persornal information. 11. Financial benefits to the participants: None.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those with persistent atrial fibrillation
* Those who admitted for elective direct-current cardioversion
* Those who aged 19 years or more

Exclusion Criteria

* Those who aged less than 19 years
* Those who had other types of cardiac arrhythmias
* Those who are not eligible to perform electrical cardioversion

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No